SEED
SEED was founded in 1957 and since, has become the largest disposable contact lens manufacturer in Japan. Beginning contact lens research in 1951, SEED have been supplying contact lenses, lens care products, and spectacles in Japan for more than half a century. SEED are dedicated to providing safe and comfortable contact lenses for every individual.
Now the SEED brand is on the way to making its mark internationally. SEED products are available in Japan, China, Hong Kong and Macau, Taiwan, Singapore, Malaysia, Vietnam, Philippines, Indonesia, Mongolia and India. In Europe, SEED products are available in Nordic countries, Italy, Switzerland, Portugal and Netherlands.
In April 2018, SEED acquired UltraVision CLPL to accelerate a full-fledged campaign across the UK and Ireland
Other relevant products
The following product(s) have not been specifically designed for myopia control and/or do not have regulatory approval for the same, but are listed by Myopia Profile as they have randomized controlled trial research data supporting their efficacy for myopia management. Suitability for prescribing these treatments will depend on your country and regulatory requirements of practice, and also be aware that not all products are available in all countries.Seed 1-Day Pure EDOF
SEED 1-day Pure EDOF is a daily disposable soft contact lens manufactured entirely in Japan. Developed in collaboration with the Brien Holden Vision Institute—a globally recognized leader in vision research—it incorporates Extended Depth-of-Focus (EDOF) technology to provide clear vision across all distances while minimizing ghosting and haloes. Originally designed to support both early myopia management and presbyopia, SEED 1-day Pure EDOF offers a seamless visual experience for a range of daily activities. Its performance as a myopia management strategy has been evaluated in a 12-month randomized controlled clinical trial.
SEED resources
Myopia Awareness Video
This video provides an essential overview of childhood myopia—what it is, why it matters, and how it can be managed. Hear expert insights from Dr. Kah Ooi Tan, President of the Asia Optometric Management Academy, and Dr. Sayuri Ninomiya, Director of Itami Central Eye Clinic in Hyogo, Japan. Together, they explore the growing global concern of childhood myopia, discussing its risks, underlying mechanisms, and the importance of early intervention. Dr. Tan provides an overview of current myopia control treatment methods, while Dr. Ninomiya shares her clinical perspective and experience in managing myopic progression in children.